President Duterte had ordered the conduct of a clinical trial of Ivermectin in the Philippines, according to Domingo.
Food and Drug Administration (FDA) Director-General Eric Domingo on Tuesday said that President Rodrigo Duterte had ordered the conduct of a clinical trial of Ivermectin in the Philippines amidst the coronavirus pandemic.
When asked on the need to conduct of clinical trial on ivermectin in the Philippines, Domingo said during the Laging Handa briefing that the President ordered the Department of Health (DOH) and the Department of Science and Technology (DOST) to conduct clinical trials on ivermectin.
Domingo added that the said clinical trial will be done by the national government and the President had tasked them to do it since there’s not enough evidence yet that Ivermectin can help COVID-19 patients.
“Si Presidente, inutusan niya ang DOH and DOST na aralin ito. Gobyerno po ito, si Presidente po mismo ang nag-utos kasi kulang pa nga po ang ebidensiya na nakakatulong ang ivermectin sa COVID-19 patients,” Domingo said.
READ ALSO: Special Use Permit For Ivermectin “Issued Per Patient” — Domingo
During the Presidential press briefing, Presidential spokesperson Harry Roque Jr. later confirmed Domingo’s statement, saying that President Duterte wanted to know if there’s a basis to say that Ivermectin was effective.
“Nais malaman ng President kung may basehan na epektibo ang gamot na ito. Bakit hindi natin gamitin kung mapapatunayan na ligtas at epektibo itong ivermectin?” Roque said.
What can you say about this? Let us know in the comments below.
For more news and updates, you may feel free to visit this site more often. You may also visit Newspapers.ph via our official Facebook page and YouTube channel.